SCHEMBL22720284

SCHEMBL22720284

CCOC(=O)C1CCN(C2CN(C(=O)OC(C)(C)C)C2)C1=O

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 3/20 0.48
MAPT P10636 2/20 0.42
TP53 P04637 1/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.40
TSHR P16473 1/20 0.40
GPR119 Q8TDV5 1/20 0.39
NR1H2 P55055 1/20 0.39
KDM4E B2RXH2 2/20 0.37
GLA P06280 1/20 0.37
HPGD P15428 1/20 0.37
RECQL P46063 1/20 0.37
HSD17B10 Q99714 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
LIPE Q05469 1/20 0.36
THRB P10828 1/20 0.36
DDB1 Q16531 2/20 0.36
CRBN Q96SW2 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31257394 0.93 TP53 (0.44) FPR2MAPTTP53KMT2AMEN1
SCHEMBL22720447 0.91 TP53 (0.51) FPR2MAPTTP53KMT2AMEN1
SCHEMBL22724577 0.88 FPR2 (0.41) FPR2MAPTTP53KMT2AMEN1
SCHEMBL22720287 0.85 FPR2 (0.39) FPR2MAPTTP53KMT2AMEN1
SCHEMBL22720310 0.84 FPR2 (0.52) FPR2MAPTTP53GPR119NR1H2
SCHEMBL22999540 0.82 FPR2 (0.42) FPR2MAPTTP53KMT2AMEN1
SCHEMBL3543973 0.80 MEN1 (0.45) MAPTKMT2AMEN1ALDH1A1TSHR
SCHEMBL652243 0.78 MEN1 (0.45) MAPTTP53KMT2AMEN1ALDH1A1
SCHEMBL19073726 0.78 MEN1 (0.45) MAPTTP53KMT2AMEN1ALDH1A1
SCHEMBL1622326 0.77 MAPT (0.43) MAPTTP53KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250145589-A1 PYRIDINE DERIVATIVE AND USE THEREOF SICHUAN HUIYU PHARMACEUTICAL CO., LTD. (CN) 2025-05-08 US disclosed
EP-4406948-A1 PYRIDINE DERIVATIVE AND USE THEREOF Sichuan Huiyu Pharmaceutical Co., Ltd. (CN) 2024-07-31 EP disclosed
CN-113396147-B Aromatic heterocyclic derivative regulator, preparation method and application thereof 上海翰森生物医药科技有限公司 2024-06-18 CN disclosed
CN-117957219-A Pyridine derivative and application thereof 四川汇宇制药股份有限公司 2024-04-30 CN disclosed
CN-113396147-A Aromatic heterocyclic derivative regulator, preparation method and application thereof 上海翰森生物医药科技有限公司 2021-09-14 CN disclosed
WO-2020239123-A1 AROMATIC HETEROCYCLIC DERIVATIVE MODULATOR AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海翰森生物医药科技有限公司 2020-12-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250145589-A1 PYRIDINE DERIVATIVE AND USE THEREOF KRAS, NRAS, BRAF FPR2 4041/4885MAPT 3897/4885TP53 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.